RESULTS: 300 patients averaging 12.3 months were included. Cleft distribution included: Submucosal-1%, Veau 1-17.3%, Veau 2-38.3%, Veau 3-30.3%, Veau 4-13.0%. Pierre Robin (N=43) was the most prevalent syndrome/anomaly. 83% of patients received paralytic reversal and total narcotic dose averaged 0.19 mg/kg. 69 patients (23.0%) had an A.P.E., most frequently hypoventilation (10%) and airway obstruction (8%). Major A.P.E. included reintubation (4.7%) and laryngobronchospasm (3.3%).
A.P.E. was associated with difficult intubation (OR=7.2), abnormal airway anatomy (OR=3.8), operation>160 minutes (OR=2.4), narcotic dose>0.3 mg/kg (OR=2.2), and inexperienced provider (OR=2.0), while paralytic reversal was protective (OR=0.5). Patients were risk-stratified according to individual profiles as low, average, high, or extreme risk (A.P.E. 2.5%-70.4%) with excellent risk discrimination (C-statistic=0.79).
CONCLUSION:
A.P.E. incidence was 23.0% after palatoplasty with 30-fold higher incidence in extreme risk patients. 2 .
